Natera Inc (NTRA)
87.22
-3.11
(-3.44%)
USD |
NASDAQ |
Apr 18, 16:00
86.00
-1.22
(-1.40%)
After-Hours: 20:00
Natera Cash from Financing (Quarterly): 6.845M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.845M |
September 30, 2023 | 236.00M |
June 30, 2023 | 9.312M |
March 31, 2023 | 2.301M |
December 31, 2022 | 468.17M |
September 30, 2022 | 1.393M |
June 30, 2022 | 8.918M |
March 31, 2022 | 4.156M |
December 31, 2021 | 8.515M |
September 30, 2021 | 554.76M |
June 30, 2021 | 8.344M |
March 31, 2021 | 4.57M |
December 31, 2020 | 11.79M |
September 30, 2020 | 275.62M |
June 30, 2020 | 209.60M |
March 31, 2020 | 3.826M |
December 31, 2019 | 220.62M |
September 30, 2019 | 4.433M |
June 30, 2019 | 113.15M |
March 31, 2019 | 2.578M |
Date | Value |
---|---|
December 31, 2018 | 3.03M |
September 30, 2018 | 104.64M |
June 30, 2018 | 5.488M |
March 31, 2018 | 0.564M |
December 31, 2017 | 2.035M |
September 30, 2017 | 75.90M |
June 30, 2017 | 2.029M |
March 31, 2017 | 0.413M |
December 31, 2016 | 2.492M |
September 30, 2016 | 0.454M |
June 30, 2016 | 8.932M |
March 31, 2016 | 1.306M |
December 31, 2015 | 15.32M |
September 30, 2015 | 178.00M |
June 30, 2015 | -2.448M |
March 31, 2015 | -0.588M |
December 31, 2014 | 58.56M |
September 30, 2014 | -0.949M |
June 30, 2014 | -1.349M |
March 31, 2014 | -0.125M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
1.393M
Minimum
Sep 2022
554.76M
Maximum
Sep 2021
113.28M
Average
8.918M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
Exact Sciences Corp | 10.04M |
Mettler-Toledo International Inc | -248.97M |
Invitae Corp | -3.381M |
Illumina Inc | -27.00M |
Castle Biosciences Inc | -3.297M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -58.12M |
Cash from Investing (Quarterly) | 24.66M |
Free Cash Flow | -286.15M |
Free Cash Flow Per Share (Quarterly) | -0.5671 |
Free Cash Flow to Equity (Quarterly) | -67.95M |
Free Cash Flow to Firm (Quarterly) | -67.66M |
Free Cash Flow Yield | -2.85% |